Beta Bionics, Inc. (BBNX) Depreciation & Amortization (CF) (2024 - 2026)

Beta Bionics (BBNX) posted Depreciation & Amortization (CF) of $600000.0 for Q1 2026, little changed sequentially from $600000.0 in Q4 2025, and up 98.02% YoY from $303000.0 in Q1 2025.

Beta Bionics, Inc. (BBNX) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends

Beta Bionics (BBNX) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $600000.0 in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 98.02% year-over-year to $600000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 62.55% YoY) and the FY2025 annual result came in at $1.6 million, up 39.01% from the prior year.
  • Depreciation & Amortization (CF) steadied at $600000.0 in Q1 2026 per BBNX's latest filing, from $600000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $600000.0 in Q4 2025, with the low at $251000.0 in Q4 2024.
  • Average Depreciation & Amortization (CF) over 3 years is $372333.3, with a median of $313000.0 recorded in 2024.
  • The widest YoY moves for Depreciation & Amortization (CF): up 139.04% in 2025, down 5.57% in 2025.
  • Beta Bionics' Depreciation & Amortization (CF) stood at $251000.0 in 2024, then jumped by 139.04% to $600000.0 in 2025, then changed by 0.0% to $600000.0 in 2026.
  • Business Quant data shows BBNX's Depreciation & Amortization (CF) at $600000.0 in Q1 2026, $600000.0 in Q4 2025, and $350000.0 in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 600,000.00
Mar 31, 2026 600,000.00
Dec 31, 2025 600,000.00
Dec 31, 2025 600,000.00
Sep 30, 2025 350,000.00
Sep 30, 2025 350,000.00
Jun 30, 2025 347,000.00
Jun 30, 2025 347,000.00
Mar 31, 2025 303,000.00
Mar 31, 2025 303,000.00
Dec 31, 2024 251,000.00
Dec 31, 2024 251,000.00
Sep 30, 2024 300,000.00
Sep 30, 2024 300,000.00
Jun 30, 2024 313,000.00
Jun 30, 2024 313,000.00
Mar 31, 2024 287,000.00
Mar 31, 2024 287,000.00